"Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol"
written by Ruth Gallily, Zhannah Yekhtin, Lumír Ondřej Hanuš,
published by Pharmacology & Pharmacy, Vol.6 No.2, 2015
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Natural cannabinoids bioavailability (1/6)
[2] Breaking the Cycle of Opioid Addiction: Supplement Your Pain Management with Cannabis
2018
[3] A Novel Observational Method for Assessing Acute Responses to Cannabis: Preliminary Validation Using Legal Market Strains
2018
[4] Medicinal Cannabis and the Tyranny of Distance: Policy Reform Required for Optimizing Patient and Health System Net Benefit in Australia
Applied Health Economics and Health Policy, 2018
[5] Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research
International Review of Psychiatry, 2018
[6] Researching safety and efficacy of CBD, hemp extracts
Natural Products Insider, 2018
[7] Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice
Inflammopharmacology, 2018
[8] Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
2018
[9] Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2018
[10] Treatment of Insomnia: Cannabis Reconsidered, Part Three Cannabis has complex effects that may complicate its use as insomnia treatment.
2017
[11] Complimentary and personal copy for
2017
[12] Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts
2017
[13] Review of Contemporary Knowledge of the Treatment Effects of Cannabis and Related Products and Its Outlook
2017
[14] Representações sociais da planta Cannabis na religião do Santo Daime: entre a sagrada Santa Maria ea proibida maconha
2017
[15] The Health Shadow Price and Economically Meaningful Threshold Values
Health Economics from Theory to Practice, 2017
[16] Policy Implications and Applications Across Health and Aged Care Reform with Baby Boomer Ageing-from Age and Dementia Friendly Communities to Palliative Care
Health Economics from Theory to Practice, 2017
[17] Cannabidiol as a Treatment for Seizures, Convulsions and Epilepsy
Cannabis sativa L. - Botany and Biotechnology, 2017
[18] Pharmacological Foundations of Cannabis Chemovars
2017
[19] Marijuana on the Mind? The Impact of Marijuana on Cognition, Brain Structure, and Brain Function, and Related Public Policy Implications
Policy Insights from the Behavioral and Brain Sciences, 2017
[20] Targeting the endocannabinoid system: future therapeutic strategies
Drug Discovery Today, 2016
[21] Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
2016
[22] Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues. Front. Pharmacol. 7: 309. doi: 10.3389/fphar. 2016.00309
2016
[23] Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia
European Journal of Pharmacology, 2016
[24] Spring Harbor Hospital in-patient medical marijuana initiative
2015
[25] A nutraceutical role for cannabidiol. Why not?
Nutrafoods, 2015
[26] Characterisation of cannabinoid composition in a diverse Cannabis sativa L. germplasm collection
Euphytica, 2015